Loading insider details...
Latest Form 4 (Oct 20, 2026): Exercise/Conversion of 3,562 RLYB shares, $8.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 20, 2026 | Rallybio Corp (RLYB) | Exercise/Conversion | 3,562 | $8.5K |
| May 22, 2026 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/Award | 6,090 | n/a |
| May 11, 2026 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Exercise/Conversion | 599 | $5.1K |
| Apr 1, 2026 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Exercise/Conversion | 599 | $5.1K |
| Mar 26, 2026 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Exercise/Conversion | 27,594 | $232.9K |
| May 22, 2025 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/Award | 12,500 | n/a |
| May 15, 2025 | Rallybio Corp (RLYB) | Grant/Award | 28,500 | n/a |
| Jun 17, 2024 | uniQure N.V. (QURE) | Sale | 2,220 | $11.4K |
| May 28, 2024 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/Award | 11,000 | n/a |
| May 17, 2024 | Rallybio Corp (RLYB) | Grant/Award | 16,500 | n/a |